Clin2
NCT07632157Possibly a fitNot yet recruiting

Magnesium with metoprolol for fast heartbeat from atrial fibrillation

Atrial Flutter With Rapid Ventricular Response

Treatments studied

Part of Heart & circulation clinical trials.

This study tests whether adding magnesium to the standard heart-rate medicine metoprolol helps control a fast heartbeat better in people with atrial fibrillation. It may help slow the heart rate more quickly and reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
196 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have atrial fibrillation or atrial flutter with a heart rate of 120 beats per minute or higher.
  • You are already receiving metoprolol to control your heart rate.
  • You can speak English and give informed consent.
  • You are not currently in a medical emergency such as very low blood pressure, heart attack, or acute heart failure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06376916Recruiting· Phase 3
Testing magnesium doses for fast heart rate in atrial fibrillation

This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.

Oak Lawn, Illinois
NCT06276127Not yet recruiting· Phase 3
Comparing two heart-rate medicines for rapid atrial fibrillation or flutter

This trial tests two medicines — one taken by mouth (bisoprolol) and one given through an IV (diltiazem) — to see which is better at safely slowing a too-fast heartbeat in people with atrial fibrillation or flutter. If you have this heart rhythm problem with a fast rate and are otherwise stable, the study might help find the most effective way to bring your heart under control.

Muscat, Al-khod
NCT05829317Recruiting· Phase 4
Magnesium to prevent new atrial fibrillation in ICU patients

This trial tests whether giving magnesium can lower the chance of developing new irregular heartbeat (atrial fibrillation) in critically ill adults in the ICU. If you are at risk but do not already have this rhythm issue, magnesium may help prevent it.

Hamilton, Ontario
NCT07706075Not yet recruiting· Phase 4
Comparing two heart medicines for fast, irregular heartbeat

This study compares two medications, verapamil and metoprolol, given in the emergency department to slow down a fast, irregular heartbeat caused by atrial fibrillation. It aims to find which medicine works better and is safer for patients like you.

NCT06716021Recruiting· Phase 3
Etripamil for rapid heart rate in atrial fibrillation

This trial tests a medication called etripamil to see if it can quickly slow down a rapid heart rate during episodes of atrial fibrillation. It may help people who have frequent, long-lasting episodes with a fast heartbeat.

West Hills, California
NCT07445789Not yet recruiting· Phase 4
Self-management with verapamil or metoprolol for paroxysmal atrial fibrillation

This trial compares two medications that control heart rate, verapamil and metoprolol, taken only when you feel an episode of paroxysmal atrial fibrillation (short, irregular heartbeats). It also tests a smartphone app that helps you manage your condition. The goal is to see if this approach improves symptoms and reduces episodes.

Hear when a new Atrial Flutter With Rapid Ventricular Response trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.